Testing effectiveness (Phase 2)Study completedNCT00278213
What this trial is testing
Combination Chemotherapy Followed By Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia
Who this might be right for
Prolymphocytic Leukemia
German CLL Study Group 17